Literature DB >> 22899556

Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Jérôme Boursier1, Jean-Pierre Zarski, Victor de Ledinghen, Marie-Christine Rousselet, Nathalie Sturm, Brigitte Lebail, Isabelle Fouchard-Hubert, Yves Gallois, Frédéric Oberti, Sandrine Bertrais, Paul Calès.   

Abstract

UNLABELLED: Liver stiffness evaluation (LSE) is usually considered as reliable when it fulfills all the following criteria: ≥10 valid measurements, ≥60% success rate, and interquartile range / median ratio (IQR/M) ≤0.30. However, such reliable LSE have never been shown to be more accurate than unreliable LSE. Thus, we aimed to evaluate the relevance of the usual definition for LSE reliability, and to improve reliability by using diagnostic accuracy as a primary outcome in a large population. 1,165 patients with chronic liver disease from 19 French centers were included. All patients had liver biopsy and LSE. 75.7% of LSE were reliable according to the usual definition. However, these reliable LSE were not significantly more accurate than unreliable LSE with, respectively: 85.8% versus 81.5% well-classified patients for the diagnosis of cirrhosis (P = 0.082). In multivariate analyses with different diagnostic targets, LSE median and IQR/M were independent predictors of fibrosis staging, with no significant influence of ≥10 valid measurements or LSE success rate. These two reliability criteria determined three LSE groups: "very reliable" (IQR/M ≤0.10), "reliable" (0.10< IQR/M ≤0.30, or IQR/M >0.30 with LSE median <7.1 kPa), and "poorly reliable" (IQR/M >0.30 with LSE median ≥7.1 kPa). The rates of well-classified patients for the diagnosis of cirrhosis were, respectively: 90.4%, 85.8%, and 69.5% (P < 10(-3) ). According to these new reliability criteria, 9.1% of LSE were poorly reliable (versus 24.3% unreliable LSE with the usual definition, P < 10(-3) ), 74.3% were reliable, and 16.6% were very reliable.
CONCLUSION: The usual definition for LSE reliability is not relevant. LSE reliability depends on IQR/M according to liver stiffness median level, defining thus three reliability categories: very reliable, reliable, and poorly reliable LSE. (HEPATOLOGY 2013).
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 22899556     DOI: 10.1002/hep.25993

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  147 in total

Review 1.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

3.  Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.

Authors:  Wah-Kheong Chan; Nik Raihan Nik Mustapha; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Sanjiv Mahadeva
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

4.  Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.

Authors:  Luca Rinaldi; Maria Guarino; Alessandro Perrella; Pia Clara Pafundi; Giovanna Valente; Luca Fontanella; Riccardo Nevola; Barbara Guerrera; Natalina Iuliano; Michele Imparato; Alessio Trabucco; Ferdinando Carlo Sasso; Filomena Morisco; Antonio Ascione; Guido Piai; Luigi Elio Adinolfi
Journal:  Dig Dis Sci       Date:  2019-04-01       Impact factor: 3.199

5.  Percutaneous liver biopsy practice patterns among Canadian hepatologists.

Authors:  Mohammed Aljawad; Eric M Yoshida; Julia Uhanova; Paul Marotta; Natasha Chandok
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

6.  Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound.

Authors:  Christophe Cassinotto; Marie-Ange Pierredon-Foulongne; Ali Belgour; Julien Delicque; Laure Escal; Nicolas Molinari; Sophie Anselme; Tony Jacq; Ugo Chamard-Champliaud; Bastien Nicolan; Carole Allimant; Boris Guiu
Journal:  Eur Radiol       Date:  2019-10-14       Impact factor: 5.315

7.  Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Authors:  Ken Liu; Vincent Wai-Sun Wong; Keith Lau; Sienna Du Liu; Yee-Kit Tse; Terry Cheuk-Fung Yip; Raymond Kwok; Alex Yiu-Wa Chan; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 8.  Critical comparison of elastography methods to assess chronic liver disease.

Authors:  Mireen Friedrich-Rust; Thierry Poynard; Laurent Castera
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

9.  Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.

Authors:  Antoine Jaquet; Marcellin Nouaman; Judicaël Tine; Aristophane Tanon; Camille Anoma; André Inwoley; Alain Attia; Didier K Ekouevi; Moussa Seydi; François Dabis; Gilles Wandeler
Journal:  Liver Int       Date:  2017-06-22       Impact factor: 5.828

Review 10.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.